UFC welterweight Viscardi Andrade has been suspended for two years by USADA for an anti-doping violation stemming from an out-of-competition urine test collected on March 7, 2016.
Andrade tested positive for stanozolol and its metabolites, 16β‐hydroxy‐stanozolol and 3’‐hydroxy‐stanozolol, which are banned substances in the category of anabolic agents. Andrade’s two-year suspension began on March 20, 2016, one day after a unanimous decision victory over Richard Walsh at UFC Fight Night 85 in Brisbane, Australia.
“Per the UFC Anti-Doping Policy, an Anti-Doping Policy Violation occurring during, or in connection with, a bout may, upon the decision of UFC, lead to disqualification of all the athlete’s results obtained in that bout,” the USADA statement read. “Here, because Andrade’s violation resulted from a sample collection that occurred prior to his bout, all information surrounding Andrade’s positive test and sanction has been provided to UFC to make the determination concerning his competition results.”
Andrade must remain in the drug-testing pool for the duration of his suspension. Including the win over Walsh, the 33-year-old Sao Paulo native is 3-1 during his UFC tenure. Andrade is 19-6 over the course of a professional career that began in 2006.